We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$544M
AUM Growth
+$18.9M
Cap. Flow
-$3M
Cap. Flow %
-0.55%
Top 10 Hldgs %
37.64%
Holding
160
New
23
Increased
37
Reduced
26
Closed
2

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$6.46M
2
MRK icon
Merck
MRK
+$4.94M
3
LMT icon
Lockheed Martin
LMT
+$4.41M
4
DHI icon
D.R. Horton
DHI
+$2.25M
5
PYPL icon
PayPal
PYPL
+$1.66M

Sector Composition

Rank Sector Weight
1 Financials 21.26%
2 Healthcare 17.86%
3 Technology 17.65%
4 Consumer Discretionary 10.87%
5 Communication Services 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
26
DELISTED
Allergan plc
AGN
$8.53M 1.57%
52,124
+13,425
+35% +$2.41M
GS icon
27
Goldman Sachs
GS
$303B
$8.44M 1.55%
33,112
+355
+1% +$87.1K
SLB icon
28
SLB Ltd
SLB
$75B
$7.71M 1.42%
114,458
+23,575
+26% +$1.53M
MRK icon
29
Merck
MRK
$318B
$7.64M 1.4%
142,224
-89,092
-39% -$4.94M
ENOV icon
30
Enovis
ENOV
$1.53B
$7.04M 1.3%
103,273
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.32T
$6.84M 1.26%
130,740
JPM icon
32
JPMorgan Chase
JPM
$950B
$6.48M 1.19%
60,610
CSCO icon
33
Cisco
CSCO
$479B
$6.18M 1.14%
161,251
+130
+0.1% +$4.64K
AMAT icon
34
Applied Materials
AMAT
$428B
$6.04M 1.11%
118,105
-715
-0.6% -$38.7K
EW icon
35
Edwards Lifesciences
EW
$51.7B
$5.89M 1.08%
156,900
+15,300
+11% +$562K
DD icon
36
DuPont de Nemours
DD
$19.2B
$5.86M 1.08%
32,509
+23,693
+269% +$4.27M
CRM icon
37
Salesforce
CRM
$158B
$4.19M 0.77%
+41,000
New +$4.18M
PG icon
38
Procter & Gamble
PG
$339B
$3.6M 0.66%
39,155
-150
-0.4% -$13.5K
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$126B
$3.04M 0.56%
20,302
-405
-2% -$60K
DLPH
40
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$2.66M 0.49%
+50,757
New +$2.64M
ABBV icon
41
AbbVie
ABBV
$435B
$2.55M 0.47%
26,345
-250
-0.9% -$23.6K
MMM icon
42
3M
MMM
$94.3B
$2.54M 0.47%
12,907
GILD icon
43
Gilead Sciences
GILD
$165B
$2.12M 0.39%
29,605
WFC.PRL icon
44
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.93M 0.36%
1,475
+80
+6% +$106K
RDS.A
45
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.84M 0.34%
27,574
ALB icon
46
Albemarle
ALB
$15.5B
$1.65M 0.3%
12,917
-1,041
-7% -$141K
VZ icon
47
Verizon
VZ
$196B
$1.62M 0.3%
30,675
+6,750
+28% +$332K
XOM icon
48
ExxonMobil
XOM
$634B
$1.61M 0.3%
19,268
+350
+2% +$28.9K
CYS.PRB
49
DELISTED
CYS Investments, Inc.
CYS.PRB
$1.56M 0.29%
63,050
+2,000
+3% +$49.6K
GE icon
50
GE Aerospace
GE
$384B
$1.33M 0.24%
15,921

Similar funds

Kelly Lawrence W & Associates's Q4 2017 Portfolio in Review

As of Q4 2017, Kelly Lawrence W & Associates held 160 positions worth $544M, up 3.6% from $525M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Kelly Lawrence W & Associates's Q4 2017 filing shows 23 new, 37 increased, 26 reduced and 2 closed positions. Its largest new stake was Salesforce: 41,000 shares worth $4.19M. The largest sale was Alkermes, an estimated $6.46M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

  • Kelly Lawrence W & Associates's largest Q4 2017 buy was Salesforce: 41,000 shares worth $4.19M.
  • Kelly Lawrence W & Associates added most to DuPont de Nemours in Q4 2017, an estimated $4.27M increase.
  • Kelly Lawrence W & Associates's biggest Q4 2017 reduction was Alkermes, cutting an estimated $6.46M.
  • Kelly Lawrence W & Associates fully exited Southwestern Energy Company in Q4 2017, selling an estimated $273K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 38% of its $544M portfolio in Q4 2017.
  • Kelly Lawrence W & Associates opened 23 new positions and closed 2 in Q4 2017.
  • Kelly Lawrence W & Associates's portfolio value rose 3.6% quarter-over-quarter to $544M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.